Evidence map›Paper›PMID 39408750›Full record

ArticleInternational journal of molecular sciences2024

Exploring Senolytic and Senomorphic Properties of Medicinal Plants for Anti-Aging Therapies.

Monika Imb, Zsolt Véghelyi, Michael Maurer, Harald Kühnel

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Apiin Promotes Healthy Aging inInternational journal of molecular sciences · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Current issues in molecular biology · 2025
    Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Monika ImbDepartment of Applied Life Sciences, Bioengineering, University of Applied Sciences Campus Wien, Favoritenstraße 222, 1100 Vienna, Austria.
Zsolt VéghelyiDepartment of Applied Life Sciences, Bioengineering, University of Applied Sciences Campus Wien, Favoritenstraße 222, 1100 Vienna, Austria.
Michael MaurerDepartment of Applied Life Sciences, Bioengineering, University of Applied Sciences Campus Wien, Favoritenstraße 222, 1100 Vienna, Austria.ORCID 0000-0003-1316-0903
Harald KühnelDepartment of Applied Life Sciences, Bioengineering, University of Applied Sciences Campus Wien, Favoritenstraße 222, 1100 Vienna, Austria.ORCID 0000-0002-4780-8061

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Senolytic and senomorphic therapies have gained more and more attention in the last decade. This kind of therapy is based on the killing of cellular senescent cells without harming the "normal" cells. Aging is not a disease. Clinical studies on healthy people will be difficult to conduct. Therefore, one possibility is to draw on the large repertoire of medicinal plants and use their senolytic properties to provide mild anti-aging therapies. Chamomile, goldenrod,

Indexed as

AntioxidantsCellular SenescencePlant ExtractsPlants, MedicinalAgingChamomileEtoposideFibroblastsHumansPolyphenolsQuercetinSenotherapeuticsAntioxidantsEtoposidePlant ExtractsPolyphenolsQuercetinSenotherapeuticschamomileetoposideherbal extractsinflammationsenolyticssenomorphics

Identifiers

PMID39408750
PMCPMC11476546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.